At PharmaBlock, technology innovation is an essential component of our commitment to providing efficient, cost-effective, high-quality, and reliable services to partners, and fulfilling our social responsibility for sustainability. The company has developed a comprehensive suite of solutions, featuring flow chemistry, micropacked bed hydrogenation, biocatalysis, heterogeneous catalysis, etc., to reduce the carbon footprint, address the chemical challenges, and make pharmaceutical production more efficient and safer.

The development and application of new technologies has enabled more innovative solutions, with shortened lead time and reduced overall costs for development and manufacturing projects, and bring long-term value to our customers.

To recognize PharmaBlock's outstanding efforts and achievement in green chemistry in support of pharmaceutical research, development, and manufacturing, American Chemical Society (ACS) Green Chemistry Institute Pharmaceutical Roundtable (GCI PR) presented PharmaBlock 2023 and 2024 CMO Excellence in Green Chemistry Award.